← Evidence map

ReviewInfectious diseases & clinical microbiology2024

Discontinuation of Nucleos(t)ide Analogues in HBeAg Negative Chronic Hepatitis B Patients: Risks and Benefits.

Pınar Korkmaz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39005698